These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1847194)

  • 1. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma.
    Packer RJ; Sutton LN; Goldwein JW; Perilongo G; Bunin G; Ryan J; Cohen BH; D'Angio G; Kramer ED; Zimmerman RA
    J Neurosurg; 1991 Mar; 74(3):433-40. PubMed ID: 1847194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report.
    Packer RJ; Siegel KR; Sutton LN; Evans AE; D'Angio G; Rorke LB; Bunin GR; Schut L
    Ann Neurol; 1988 Oct; 24(4):503-8. PubMed ID: 3239953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
    Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
    N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primitive neuroectodermal tumors.
    Goldwein JW; Radcliffe J; Packer RJ; Sutton LN; Lange B; Rorke LB; D'Angio GJ
    Cancer; 1993 Apr; 71(8):2647-52. PubMed ID: 8384073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
    Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
    Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
    Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
    Packer RJ
    Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
    Evans AE; Jenkin RD; Sposto R; Ortega JA; Wilson CB; Wara W; Ertel IJ; Kramer S; Chang CH; Leikin SL
    J Neurosurg; 1990 Apr; 72(4):572-82. PubMed ID: 2319316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience.
    Paulino AC; Melian E
    Cancer; 1999 Jul; 86(1):142-8. PubMed ID: 10391574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
    Rutkauskiene G; Labanauskas L
    Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
    Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
    J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
    J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
    Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
    Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.